Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2021-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2021-1
HYC
FNCL
HAXNP 2021-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
CEN
,
CIS
,
DGX
,
FSH
,
...
APAC
Jan 27, 2021
Missing something? Tell us.